Schrödinger is a leading computational platform for drug discovery and materials science. The company combines physics-based modeling with machine learning to accelerate the discovery of novel therapeutics and advanced materials.
Its software platform enables scientists to predict the properties of molecules with high accuracy, guiding experimental efforts and reducing the time and cost of research and development.
Schrödinger collaborates with pharmaceutical, biotechnology, and materials companies worldwide, as well as academic institutions, to solve complex challenges in life science and industrial research.